July 3, 2012

The Food and Drug Administration has approved over-the-counter sales of a test for the virus that causes AIDS, the agency said Tuesday.

July 3, 2012

Specialty pharmacy provider The Apothecary Shops has acquired a Denver-based pharmacy, according to published reports.

June 29, 2012

The Food and Drug Administration has granted priority review for an investigational cancer treatment created by Bayer and Onyx Pharmaceuticals.

June 29, 2012

Drug maker Gilead Sciences has submitted a regulatory approval application to the Food and Drug Administration for a drug designed to increase the blood levels of certain drugs for HIV.

June 29, 2012

While saying the Patient Protection and Affordable Care Act — whose constitutionality the Supreme Court largely upheld in a 5-4 decision Thursday — would be beneficial by creating a larger population of insured patients, the leader of one of the country's largest specialty pharmacies said it didn't address the problem of waste in health care, according to published reports.

June 28, 2012

The Supreme Court on Thursday identified the Patient Protection and Affordable Care Act as a tax, which means the constitutionality of the healthcare-reform package cannot be addressed until after that tax is assessed.

June 28, 2012

A new continuing-education program offered by a national pharmacist professional organization aims to prepare pharmacists to communicate with patients about the safe and effective use of the painkiller acetaminophen.

June 28, 2012

While the Supreme Court on Thursday morning left the Patient Protection and Affordable Care Act mostly intact, the court did rule that Congress cannot withhold federal Medicaid spending from a state that does not expand its eligibility requirements under the act.

June 27, 2012

A bill passed in the Senate will provide measures to speed up the development of treatments for people who desperately need them.

June 26, 2012

An organization focused on Crohn's disease and ulcerative colitis has revamped its website, the group said Tuesday.

June 26, 2012

Walgreens is partnering with health authorities and service organizations to provide pharmacist-administered testing for the virus that causes AIDS, the retail pharmacy chain said.

June 25, 2012

A federal court has ruled against Mylan in a case filed by Teva Pharmaceutical Industries over a drug to treat multiple sclerosis.

June 22, 2012

A drug maker has resubmitted its new drug application to the Food and Drug Administration for an acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

June 21, 2012

The Food and Drug Administration has approved a new indication for a Pfizer drug.

June 21, 2012

The leader of the country’s largest privately owned specialty pharmacy provider had a day in Washington.

June 21, 2012

Specialty and biologically engineered medicines have been a boon to millions of Americans with life-threatening and life-altering conditions. But their lofty prices are squeezing patients and payers and spawning a growing legislative backlash that threatens insurers and employer-based health plans.

June 20, 2012

A community specialty network has teamed up with a company that helps doctors and pharmacies submit prior authorizations and other coverage determination forms for medications.

June 20, 2012

Kerr Health has integrated its specialty pharmacy and long-term care data into BioMed Intelligence's data warehouse solution, BMI said.

June 19, 2012

The Food and Drug Administration has declined to approve a drug designed to treat a rare, progressive and fatal neurodegenerative disease.

June 19, 2012

Pfizer announced the results of its late-stage clinical trial of Xalkori (crizotinib).

June 19, 2012

SXC Health Solutions has been awarded specialty pharmacy accreditation from URAC.

June 15, 2012

Valeant Pharmaceuticals International has agreed to acquire a specialty oral health company that develops and commercializes products that improve and maintain oral health.

June 14, 2012

The Apothecary Shops are rebranding to become Avella Specialty Pharmacy, effective in August, the company announced Wednesday.

June 13, 2012

Upsher-Smith Labs on Wednesday announced that it has agreed to acquire Proximagen Group, a European biotechnology company focused on the development and commercialization of novel therapeutics for diseases of the central nervous system and inflammation.